Susan A Masino, Masahito Kawamura, Jessica L Cote, Rebecca B Williams, David N Ruskin
Neuropharmacology 2013 MayIn rodents, insufficient adenosine produces behavioral and physiological symptoms consistent with several comorbidities of autism. In rodents and humans, stimuli postulated to increase adenosine can ameliorate these comorbidities. Because adenosine is a broad homeostatic regulator of cell function and nervous system activity, increasing adenosine's influence might be a new therapeutic target for autism with multiple beneficial effects. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'. Copyright © 2012 Elsevier Ltd. All rights reserved.
Susan A Masino, Masahito Kawamura, Jessica L Cote, Rebecca B Williams, David N Ruskin. Adenosine and autism: a spectrum of opportunities. Neuropharmacology. 2013 May;68:116-21
PMID: 22940000
View Full Text